AHR vs DOC vs JAN Stock Comparison

American Healthcare REIT, Healthpeak Properties and Janus Living Prices as of Nov 13, 2026 Peers: Industry group
JAN Janus Living, Inc.
$31.82 +9.8% 1M
Market cap
$7.46B
P/E
–
Revenue (TTM)
$835.56M
Div. yield
1.29%
Healthcare REITs Real Estate

Head to Head

11 decided of 12

Healthpeak Properties leads on 7 of the 12 questions below (Healthpeak Properties 7, American Healthcare REIT 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionAHRDOCJANLeader
Larger companyMarket capitalisation $13.41B $13.78B $7.46B DOC
Cheaper on earningsLower P/E, profitable companies only 130.1x 36.5x -3,327x DOC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 91.7x — 318.2x AHR
Faster revenue growthRevenue growth, trailing twelve months +21.5% +9.4% — AHR
More profitableNet margin, trailing twelve months 3.6% 12.3% -0.3% DOC
Better return on capitalReturn on invested capital -31.7% -7.1% -21.2% DOC
Less leveragedLower net debt / EBITDA -0.7x -962.8x — DOC
Higher dividend yieldTrailing dividend yield 1.73% 6.54% 1.29% DOC
Better 1-year returnPrice return, last 12 months +19.8% +14.2% — AHR
Better 5-year returnAnnualised price return, 5 years — -10.0%/yr — –
Less volatileAnnualised volatility, 1 year 26.6% 28.6% 28.9% AHR
Higher overall scoreMean of the five percentile scores vs peers 44/100 46/100 25/100 DOC

Percentile Scorecard

AHRDOCJAN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisAHRDOCJAN
Valuation 5 #141 of 149 34 #99 of 149 1 #147 of 149
Growth 86 #22 of 147 45 #82 of 147 –
Profitability 25 #109 of 144 43 #83 of 144 26 #107 of 144
Financial Health 84 #25 of 149 58 #63 of 149 72 #43 of 149
Shareholder Returns 22 #109 of 139 50 #70 of 139 2 #136 of 139
Overall 44 46 25
  • AHR ranked among 150 companies in Property REITs
  • DOC ranked among 150 companies in Property REITs
  • JAN ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodAHRDOCJANSPY
1 month +10.2%+6.7%+9.8% -2.0%
3 months +6.4%-3.8%+3.9% -2.8%
6 months +17.1%+3.3%+19.3% +2.0%
Year to date +22.8%+24.3%— +10.6%
1 year +19.8%+14.2%— +12.2%
3 years —+18.0%— +68.1%
3 years, per year —+5.7%— +18.9%
5 years —-40.9%— +61.4%
5 years, per year —-10.0%— +10.1%
10 years —-28.9%— +248.5%
10 years, per year —-3.3%— +13.3%

Risk

MeasureAHRDOCJANSPY
Volatility, 1Y 26.6%28.6%28.9% 13.6%
Downside volatility, 1Y 27.3%24.1%26.9% 13.9%
Beta vs S&P 500, 1Y 0.050.34-0.01 1.00
Return / volatility, 1Y 0.740.49— 0.90
Max drawdown, 5Y -14.5%-57.6%-13.8% -25.4%
From 52-week high -2.7%-12.4%-3.2% -3.2%
52-week high $59.40$22.83$32.88 $779.14
52-week low $45.69$15.78$22.88 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleAHRDOCJAN
P/E now vs peer median 130.1xmedian 26.1x 36.5xmedian 26.1x -3,327xmedian 26.1x
P/S now vs peer median 5.0xmedian 4.3x 4.5xmedian 4.3x 8.9xmedian 4.3x
EV/EBITDA now vs peer median -9.3xmedian 14.5x -3,321xmedian 14.5x -10.9xmedian 14.5x
P/FCF now vs peer median -20.2xmedian 21.4x -6.0xmedian 21.4x -3.5xmedian 21.4x
P/B now vs peer median 2.4xmedian 1.2x 1.3xmedian 1.2x 1.8xmedian 1.2x
PEG now vs peer median 4.02median 1.75 4.77median 1.75 —median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsAHRDOCJAN
Revenue $2.67B $3.06B $835.56M
Gross profit $589.22M $1.74B –
Operating income -$1.92B -$1.20B -$871.49M
Net income $97.45M $443.23M $38.54M
Free cash flow -$662.56M -$2.30B -$2.15B
EPS (diluted) $0.44 $0.55 $-0.01
Cash & equivalents $258.67M $514.31M $338.06M
Total debt $1.36B $6.14B –
Shares (diluted) 217.71M 689.51M 225.97M
Enterprise value $12.72B $12.92B $5.61B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricAHRDOCJAN
P/E 130.1x 36.5x -3,327x
P/FCF -20.2x -6.0x -3.5x
P/Operating cash flow 31.8x 10.8x 30.0x
P/S 5.0x 4.5x 8.9x
P/B 2.4x 1.3x 1.8x
P/Tangible book 2.6x 1.4x 2.0x
EV/EBITDA -9.3x -3,321x -10.9x
EV/EBIT -7.6x -16.2x -8.2x
EV/Revenue 5.4x 6.3x 8.5x
EV/FCF -21.9x -8.4x -3.3x
EV/Operating cash flow 34.4x 15.3x 28.7x
PEG (3Y EPS CAGR) 4.02 4.77 –

Growth

14 metrics
MetricAHRDOCJAN
Revenue growth (1Y) 21.5% 9.4% –
Revenue CAGR (3Y) 16.8% 12.5% –
Gross profit growth (1Y) 29.5% 3.4% –
Gross profit CAGR (3Y) 43.5% 11.6% –
Operating income growth (1Y) -21.6% -83.3% –
Operating income CAGR (3Y) -6.8% -92.0% –
Net income growth (1Y) 255.0% 2,652% –
Net income CAGR (3Y) 44.8% 17.9% –
EPS growth (1Y) 175.6% 1,076% –
EPS CAGR (3Y) 32.4% 7.7% –
Operating cash flow growth (1Y) 41.2% 2.3% –
Operating cash flow CAGR (3Y) 57.9% 10.9% –
Free cash flow growth (1Y) -1,027% -787.4% –
Free cash flow CAGR (3Y) -114.2% -326.3% –

Profitability

14 metrics
MetricAHRDOCJAN
Gross margin 22.1% 56.8% –
EBITDA margin -58.3% -0.2% -78.3%
Operating margin -71.8% -39.2% -104.3%
Pretax margin 3.6% 13.5% 4.7%
Net margin 3.6% 12.3% -0.3%
FCF margin -24.8% -75.1% -257.6%
Operating cash flow margin 15.8% 41.5% 29.7%
Return on equity 2.1% 4.2% 1.0%
Return on assets 1.5% 1.9% 0.8%
Return on invested capital -31.7% -7.1% -21.2%
Return on capital employed – – –
Asset turnover 0.4x 0.1x 0.2x
Cash conversion (OCF / net income) 4.3x 2.9x 6.4x
Stock comp / revenue 0.9% 0.6% 0.1%

Financial Health

11 metrics
MetricAHRDOCJAN
Debt / assets 17.9% 27.4% –
Debt / equity 0.2x 0.6x –
Net debt / EBITDA -0.7x -962.8x –
Debt / FCF -2.1x -2.7x –
Liabilities / assets 26.6% 51.9% 21.0%
Equity / assets 73.4% 48.1% 79.0%
Interest coverage -25.6x -14.7x -407.8x
Current ratio – – –
Quick ratio – – –
Cash ratio – – –
Altman Z-score – – –

Shareholder Returns

7 metrics
MetricAHRDOCJAN
Dividend yield 1.7% 6.5% 1.3%
Net buyback yield -22.2% 0.7% -11.2%
Shareholder yield -20.5% 7.3% -9.9%
Payout ratio (earnings) 190.9% 190.5% –
Payout ratio (FCF) -28.1% -36.7% –
Dividend growth (1Y) 17.0% 0.3% –
Dividend CAGR (3Y) 35.1% -8.9% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusAHRDOCJAN
Forward P/E 91.7xFY2026 – 318.2xFY2026
EPS, next fiscal year $0.63FY2026 – $0.10FY2026
EPS growth, next FY +50.0%FY2026 – +150.0%FY2026
EPS growth, the year after +36.5% – -10.0%
Revenue, next fiscal year $2.65BFY2026 $2.86BFY2026 $885.94MFY2026
Revenue growth, next FY +17.1%FY2026 +3.7%FY2026 +27.8%FY2026
Revenue growth, the year after +29.9% +12.9% +42.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersAHRDOCJAN
Held by institutions 100.0% 95.7% 38.1%
Institutions holding 573 761 162
Change in shares held, QoQ +19.9% -2.9% +56.8%
Institutions buying 335 341 137
Institutions selling 165 314 19
Buyers to sellers 2.03 1.09 7.21

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

AHRDOCJAN
AHR 1.00 0.31 0.60
DOC 0.31 1.00 0.35
JAN 0.60 0.35 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, AHR, DOC and JAN?

Healthpeak Properties (DOC) is the largest by market capitalisation: American Healthcare REIT (AHR) $13.41B, Healthpeak Properties (DOC) $13.78B, Janus Living (JAN) $7.46B.

Which stock is cheaper, AHR, DOC and JAN?

Healthpeak Properties (DOC) trades on the lowest price-to-earnings ratio (American Healthcare REIT (AHR) 130.1x, Healthpeak Properties (DOC) 36.5x, Janus Living (JAN) -3,327x). On next year's consensus earnings, American Healthcare REIT (AHR) is cheapest (American Healthcare REIT (AHR) 91.7x, Janus Living (JAN) 318.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

American Healthcare REIT (AHR) grew revenue fastest over the trailing twelve months: American Healthcare REIT (AHR) +21.5%, Healthpeak Properties (DOC) +9.4%.

Which company is more profitable?

Healthpeak Properties (DOC) has the highest net margin (American Healthcare REIT (AHR) 3.6%, Healthpeak Properties (DOC) 12.3%, Janus Living (JAN) -0.3%). On return on invested capital, Healthpeak Properties (DOC) leads (American Healthcare REIT (AHR) -31.7%, Healthpeak Properties (DOC) -7.1%, Janus Living (JAN) -21.2%).

Which stock has performed better?

Over the past year American Healthcare REIT (AHR) returned the most: American Healthcare REIT (AHR) +19.8%, Healthpeak Properties (DOC) +14.2%. Returns are price only, before dividends.

Which pays a higher dividend?

Healthpeak Properties (DOC) has the highest dividend yield: American Healthcare REIT (AHR) 1.73%, Healthpeak Properties (DOC) 6.54%, Janus Living (JAN) 1.29%.

Which stock is riskier?

By one-year price volatility, American Healthcare REIT (AHR) has been the steadiest (American Healthcare REIT (AHR) 26.6%, Healthpeak Properties (DOC) 28.6%, Janus Living (JAN) 28.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, AHR, DOC and JAN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Healthpeak Properties (DOC) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.